Regulation 2
Amendment of Fourth Schedule
of Misuse of Drugs (Amendment No. 2) Regulations 2026
In the Misuse of Drugs Regulations (Rg 1), in the Fourth Schedule —
in paragraph 17, after item (19AAB), insert —“(19AAC)2‑(4‑Ethoxybenzyl)‑N‑ethyl‑5‑nitro‑1H-benzimidazole‑1‑ethanamine (also known as N‑desethyl etonitazene) and its ethylamino structural isomer and their respective ethoxy positional isomers in the phenyl ring and nitro positional isomers in the 6‑membered ring of the benzimidazole structure”;
in paragraph 17, after item (36), insert —“(36AA)5‑Nitro‑2‑(4‑isopropoxybenzyl)‑1‑[2‑(pyrrolidin-1-yl)ethyl]‑1H‑benzo[d]imidazole (also known as N‑pyrrolidino isotonitazene or isotonitazepyne) and its isopropoxy structural isomers and their respective isopropoxy positional isomers in the phenyl ring and nitro positional isomers in the 6‑membered ring of the benzimidazole structure”; and
in paragraph 18, after item (36), insert —“(36A)N‑Methyl‑N‑isopropyltryptamine (also known as MiPT)”.